Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Abnormalities of Dopamine D3Receptor Signaling in the Diseased Brain
G. Aleph Prieto
Journal of Central Nervous System Disease (2017) Vol. 9, pp. 117957351772633-117957351772633
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Gi/o-Protein Coupled Receptors in the Aging Brain
Patrícia Gnieslaw de Oliveira, Marta Longchong Ramos, A Amaro, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 81
Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
K. Kawahata, David I. Finkelstein, Kohji Fukunaga
Receptors (2024) Vol. 3, Iss. 2, pp. 155-181
Open Access | Times Cited: 12
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
Pengfei Yang, Joel S. Perlmutter, Tammie L.S. Benzinger, et al.
Ageing Research Reviews (2019) Vol. 57, pp. 100994-100994
Open Access | Times Cited: 73
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Antonio Vita, Alessandra Minelli, Sergio Barlati, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 51
Identification of visual cortex cell types and species differences using single-cell RNA sequencing
Jia-Ru Wei, Zhao-Zhe Hao, Chuan Xu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit
Arantzazu Belloso-Iguerategui, Marta Zamarbide, Leyre Merino-Galán, et al.
Brain (2023) Vol. 146, Iss. 12, pp. 4949-4963
Open Access | Times Cited: 11
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia
Samantha Álvarez-Herrera, Mauricio Rosel-Vales, Gilberto Pérez‐Sánchez, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 167-167
Open Access | Times Cited: 4
The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective Agonists
Francisco O. Battiti, Sophie L. Cemaj, Adrian M. Guerrero, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 13, pp. 6287-6314
Open Access | Times Cited: 32
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Bromophenols from Symphyocladia latiuscula Target Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases
Pradeep Paudel, Se Eun Park, Su Hui Seong, et al.
Journal of Agricultural and Food Chemistry (2020) Vol. 68, Iss. 8, pp. 2426-2436
Closed Access | Times Cited: 25
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C. Gondré‐Lewis, Igor Elman, Tanya N. Alim, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 870-870
Open Access | Times Cited: 15
Gold Nanospikes Formation on Screen-Printed Carbon Electrode through Electrodeposition Method for Non-Enzymatic Electrochemical Sensor
Isa Anshori, Raih Rona Althof, Lavita Nuraviana Rizalputri, et al.
Metals (2022) Vol. 12, Iss. 12, pp. 2116-2116
Open Access | Times Cited: 14
Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice
Jia Zhan, Chloe J. Jordan, Guo‐Hua Bi, et al.
Neuropharmacology (2018) Vol. 141, pp. 11-20
Open Access | Times Cited: 21
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist
Cristina Cosi, Jean‐Claude Martel, Agnès L. Auclair, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173635-173635
Closed Access | Times Cited: 20
Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals
Chloe J. Jordan, Zheng‐Xiong Xi
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 12
The Park Sleep subtype in Parkinson’s disease: from concept to clinic
Phoebe Tall, Mubasher A. Qamar, Ivana Rosenzweig, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 15, pp. 1725-1736
Open Access | Times Cited: 6
G protein-coupled receptor heteromers are key players in substance use disorder
Lyes Derouiche, Dominique Massotte
Neuroscience & Biobehavioral Reviews (2018) Vol. 106, pp. 73-90
Open Access | Times Cited: 19
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Emma Gogarnoiu, Caleb D. Vogt, Julie Sanchez, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1809-1834
Open Access | Times Cited: 5
Integrative multi-dimensional characterization of striatal projection neuron heterogeneity in adult brain
Jenesis Gayden, Stéphanie Puig, Chaitanya Srinivasan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Modulation of D3R Splicing, Signaling, and Expression by D1R through PKA→PTB Phosphorylation
Orlando Casados-Delgado, José Arturo Ávalos‐Fuentes, Manuel Lara-Lozano, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 206-206
Open Access | Times Cited: 1
Involvement of dopamine D3 receptor in impulsive choice decision-making in male rats
Hui Shen, Zilu Ma, Emma Hans, et al.
Neuropharmacology (2024) Vol. 257, pp. 110051-110051
Closed Access | Times Cited: 1
Pramipexole Hyperactivates the External Globus Pallidus and Impairs Decision-Making in a Mouse Model of Parkinson’s Disease
Hisayoshi Kubota, Xinzhu Zhou, Xinjian Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8849-8849
Open Access | Times Cited: 1
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands
Milica Elek, Nemanja Djoković, Annika Frank, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 6
Open Access | Times Cited: 10
Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Kathryn Lanza, Christopher Bishop
Biomedicines (2021) Vol. 9, Iss. 3, pp. 314-314
Open Access | Times Cited: 10
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo
Béla Kiss, Balázs Krámos, I. Laszlovszky
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top